Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NICE Expands On Methods Review Details

Executive Summary

UK health technology appraisal body NICE has released more details about its forthcoming review of the methods it uses for developing guidance on medicines and medical devices.

You may also be interested in...



Brexit Issues Lead NICE To Delay Methods Review

England’s health technology appraisal body, NICE, and the UK medicines regulator, the MHRA, are working together to align their process timelines so that access to medicines is “maintained and enhanced.”

UK Industry Sets Out Key Asks On NICE’s Methods Review

As the National Institute for Health and Care Excellence conducts a review of its health technology assessment methods, the Association of the British Pharmaceutical Industry has laid out the key changes it would like to see.

UK NICE Review Needs To Be More Than A ‘Bureaucratic Exercise’

A review of UK HTA body NICE’s methods for appraising medicines will probably be constrained by budget considerations, but it should still aim to bring positive change, said Leslie Galloway of the Ethical Medicines Industry Group.

Related Content

Topics

UsernamePublicRestriction

Register

PS140553

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel